Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arman Qamar

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Current Cardiology Reports|June 29, 2019
Low-Density Lipoprotein Cholesterol After an Acute Coronary Syndrome: How Low to Go?Arman Qamar, Peter Libby
The Canadian Journal of Cardiology|July 8, 2020
Beta-Blocker Therapy After Myocardial Infarction: Is There an Expiry Date?Arman Qamar, Sripal Bangalore
Annals of Internal Medicine|December 24, 2019
Biomarkers to Personalize Preoperative Cardiovascular Risk Stratification: Ready for Prime Time?Arman Qamar, Sripal Bangalore
JAMA|November 7, 2018
Treatment of Hypertension: Addressing a Global Health ProblemArman Qamar, Eugene Braunwald
Nature Reviews. Nephrology|July 8, 2015
Reply: Warfarin in patients on haemodialysis with atrial fibrillation—friend or foe?Arman Qamar, Deepak L Bhatt
Circulation|April 13, 2016
Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney DiseaseArman Qamar, Deepak L Bhatt
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 13, 2016
Erratum to: Optimizing the Use of Cangrelor in the Real WorldArman Qamar, Deepak L Bhatt
Nature Reviews. Nephrology|February 11, 2015
Anticoagulation therapy: Balancing the risks of stroke and bleeding in CKDArman Qamar, Deepak L Bhatt
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 29, 2016
Optimizing the Use of Cangrelor in the Real WorldArman Qamar, Deepak L Bhatt
Pharmacology & Therapeutics|January 24, 2016
Current status of data on cangrelorArman Qamar, Deepak L Bhatt
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Current Cardiology Reports|June 29, 2019
Low-Density Lipoprotein Cholesterol After an Acute Coronary Syndrome: How Low to Go?Arman Qamar, Peter Libby
The Canadian Journal of Cardiology|July 8, 2020
Beta-Blocker Therapy After Myocardial Infarction: Is There an Expiry Date?Arman Qamar, Sripal Bangalore
Annals of Internal Medicine|December 24, 2019
Biomarkers to Personalize Preoperative Cardiovascular Risk Stratification: Ready for Prime Time?Arman Qamar, Sripal Bangalore
JAMA|November 7, 2018
Treatment of Hypertension: Addressing a Global Health ProblemArman Qamar, Eugene Braunwald
Nature Reviews. Nephrology|July 8, 2015
Reply: Warfarin in patients on haemodialysis with atrial fibrillation—friend or foe?Arman Qamar, Deepak L Bhatt
Circulation|April 13, 2016
Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney DiseaseArman Qamar, Deepak L Bhatt
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 13, 2016
Erratum to: Optimizing the Use of Cangrelor in the Real WorldArman Qamar, Deepak L Bhatt
Nature Reviews. Nephrology|February 11, 2015
Anticoagulation therapy: Balancing the risks of stroke and bleeding in CKDArman Qamar, Deepak L Bhatt
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 29, 2016
Optimizing the Use of Cangrelor in the Real WorldArman Qamar, Deepak L Bhatt
Pharmacology & Therapeutics|January 24, 2016
Current status of data on cangrelorArman Qamar, Deepak L Bhatt
Pageof 16